Citation Impact
Citing Papers
Transferred WT1-Reactive CD8 + T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients
2013
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Addition of a Low Fixed Number of CD3 + Cells to CD34-Enriched Allografts: Effects on Engraftment, Graft-versus-Host Disease, and Survival after Related and Unrelated Peripheral Stem Cell Transplantation
2003
Nucleotide Oligomerization Binding Domain-Like Receptor Signaling Enhances Dendritic Cell-Mediated Cross-Priming In Vivo
2009 StandoutNobel
Hierarchy of the Human Natural Killer Cell Response Is Determined by Class and Quantity of Inhibitory Receptors for Self-HLA-B and HLA-C Ligands
2007
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry
2014 Standout
Nod2 regulates the host response towards microflora by modulating T cell function and epithelial permeability in mouse Peyer's patches
2009
Radiation Enhances Regulatory T Cell Representation
2010
KIR matching in hematopoietic stem cell transplantation
2005
Thymoglobulin Prevents Chronic Graft-versus-Host Disease, Chronic Lung Dysfunction, and Late Transplant-Related Mortality: Long-Term Follow-Up of a Randomized Trial in Patients Undergoing Unrelated Donor Transplantation
2006
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 Standout
Contribution of platelets to tumour metastasis
2011 Standout
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Non‐HLA genetics and predicting outcome in HSCT
2008
Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma
2010
Human NK cells: from HLA class I‐specific killer Ig‐like receptors to the therapy of acute leukemias
2008
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Crohn's disease
2012 Standout
Hematopoiesis: An Evolving Paradigm for Stem Cell Biology
2008 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
The ever-expanding function of NOD2: autophagy, viral recognition, and T cell activation
2011
HSP90 and the chaperoning of cancer
2005 Standout
The biochemistry of apoptosis
2000 StandoutNature
Molecular mechanisms of cisplatin resistance
2011 Standout
Chronic graft-versus-host disease
2003 Standout
Functions of natural killer cells
2008 Standout
Cancer genes and the pathways they control
2004 Standout
Prevalence and clinical significance of anticardiolipin and anti‐β2‐glycoprotein‐I antibodies in patients with non‐Hodgkin's lymphoma
2002
Current status of the molecular mechanisms of anticancer drug-induced apoptosis
2002
Four deaths and a funeral: from caspases to alternative mechanisms
2001 Standout
The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis
2009 Standout
Different radiosensitivity of CD4+CD25+regulatory T cells and effector T cells to low dose gamma irradiation in vitro
2010
Graft-versus-host disease
2009 Standout
Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease?
2007
Biology and management of relapsed acute myeloid leukaemia
2005
Malignant Gliomas in Adults
2008 Standout
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Chronic Myelogenous Leukemia
2002
Apoptosis
2002 Standout
Prevention of Venous Thromboembolism
2004 Standout
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
2010 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
Molecular signals in anti-apoptotic survival pathways
2001
Prospects for the use of NK cells in immunotherapy of human cancer
2007
Gene Map of the HLA Region, Graves’ Disease and Hashimoto Thyroiditis, and Hematopoietic Stem Cell Transplantation
2015
Prevention of Venous Thromboembolism
2008 Standout
Genetics and pathogenesis of inflammatory bowel disease
2011 StandoutNature
Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age>55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning
2004
NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?
2010 Standout
Radiation for Awakening the Dormant Immune System, a Promising Challenge to be Explored
2014
Risk factors for chemotherapy‐associated venous thromboembolism in a prospective observational study
2005
Escaping Cell Death: Survival Proteins in Cancer
1999
Intracellular NOD-like Receptors in Host Defense and Disease
2007
Defining trained immunity and its role in health and disease
2020 Standout
Immunity to fungal infections
2011 Standout
The BCL-2 protein family: opposing activities that mediate cell death
2007 Standout
Biology and Plasticity of CD133+ Hematopoietic Stem Cells
2003
Epigenetic Regulation of Hematopoietic Differentiation by Gfi-1 and Gfi-1b Is Mediated by the Cofactors CoREST and LSD1
2007
Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects
2004
Heat shock proteins – modulators of apoptosis in tumour cells
2000
Allogeneic Transplantation of CD34+ Selected Hematopoietic Cells—Clinical Problems and Current Challenges
2003
Nucleotide-Binding Oligomerization Domain-Like Receptors: Intracellular Pattern Recognition Molecules for Pathogen Detection and Host Defense
2006
Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors
2002
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
2009 Standout
Regulatory T Cells and Human Disease
2020 StandoutNobel
Acute Myeloid Leukemia
2015 Standout
Regulation and Function of NF-κB Transcription Factors in the Immune System
2009 Standout
Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities
2004
Matched Unrelated or Matched Sibling Donors Result in Comparable Survival After Allogeneic Stem-Cell Transplantation in Elderly Patients With Acute Myeloid Leukemia: A Report From the Cooperative German Transplant Study Group
2008
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?
2011
Combining a Recombinant Cancer Vaccine with Standard Definitive Radiotherapy in Patients with Localized Prostate Cancer
2005
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self
2006
Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production
2008 StandoutNature
Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation
2003
Venous Thromboembolism and Cancer: Risks and Outcomes
2003
Management of Venous Thromboembolism in Patients With Primary and Metastatic Brain Tumors
2006
American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer
2007
Cancer treatment and survivorship statistics, 2016
2016 Standout
Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders
2012
A perspective on the selection of unrelated donors and cord blood units for transplantation
2012
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
2005 Standout
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies
2003
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Regulation of Adaptive Immunity by the Innate Immune System
2010 StandoutScience
Ionizing Radiation Selectively Reduces Skin Regulatory T Cells and Alters Immune Function
2014 StandoutNobel
Endothelial Progenitor Cells
2004 Standout
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen
2003
Heat Shock Protein 27 Protects L929 Cells from Cisplatin-Induced Apoptosis by Enhancing Akt Activation and Abating Suppression of Thioredoxin Reductase Activity
2007
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Works of Hellmut Ottinger being referenced
Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients
2011
Relevance of C1 and C2 Epitopes for Hemopoietic Stem Cell Transplantation: Role for Sequential Acquisition of HLA-C-Specific Inhibitory Killer Ig-Like Receptor
2007
In Acute Myeloid Leukemia only the Coexpression of at Least Two Proteins Including P-Glycoprotein, the Multidrug Resistance-Related Protein MRP, bcl-2, Mutant p53 and Heat-Shock Protein 27 is Predictive for the Response to Induction Chemotherapy
1998
ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML)
2003
Impact of localized radiotherapy on blood immune cells counts and function in humans
1999
Transplantation of highly purified HLA-identical sibling donor peripheral blood CD34+ cells without prophylactic post-transplant immunosuppression in adult patients with first chronic phase chronic myeloid leukemia: results of a phase II study
2000
Mutations in Innate Immune System NOD2/CARD 15 and TLR-4 (Thr399Ile) Genes Influence the Risk for Severe Acute Graft-versus-Host Disease in Patients Who Underwent an Allogeneic Transplantation
2006
Deep venous thrombosis and pulmonary artery embolism in high‐grade non Hodgkin's lymphoma: incidence, causes and prognostic relevance
1995
Positive serum crossmatch as predictor for graft failure in HLA-mismatched allogeneic blood stem cell transplantation
2002
No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors
2001
Improved disease-free–survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia
2002
Growth factor‐independent 1B gene (GFI1B) is overexpressed in erythropoietic and megakaryocytic malignancies and increases their proliferation rate
2006
Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias
2004
Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors
2003
Outcome of transplantation of highly purified peripheral blood CD34+ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia
2002